Advertisement

POZ November 2004

POZ November 2004

In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:

ISSUU

Features

POZ Magazine

Vote ’04-Who’s better for people with HIV?

Bush or Kerry? POZ tracks each man’s AIDS record- and asks the experts what may happen if either of them wins in November.

POZ Magazine

Vote ’04-We Have Issues

Meet three HIVers keeping the Democrats and Republicans honest.

POZ Magazine

Vote ’04-4 More Years?!?

With a timeline and an excerpt from her new book, Esther Kaplan replays four years of Dubya’s  AIDS policy.  Can we survive another term?

POZ Magazine

Vote ’04-Who Ya For?

POZ pundit Doug Ireland cuts to the race chase. Plus, a poll of eight pull-no-punches HIVers-including Bob Hattoy and Mary Fishers, stars...

POZ Magazine

Vote ’04-Full-Frontal Election

Presidential elections are always full of sound bites and fury, but what does Bush vs. Kerry signify for HIVers?

POZ Magazine

Vote ’04-Hot Seats

Five burning Senate races to get HIVers off their asses

Inside the Issue

POZ Magazine

1,2,3...ENTRY!

HIV wends its wily way inside CD4 cells through an eerily precise three-step process. Here’s how it happens--and how entry inhibitors...

POZ Magazine

Back to School

A campaigning educator tells HIV to sit down and be quiet

POZ Magazine

When Life Hands You Lemons...

Thais get juiced on a new lemon aid

POZ Magazine

One Hot Tomato

Saucy HIV researchers in Novosibirsk, Russia, suggest that an AIDS vaccine may be blooming in your own backyard.

POZ Magazine

Microbicide Update

At July’s world AIDS conference, researchers lined up to hype the womanly wonders of HIV-fighting vaginal gels.

POZ Magazine

Sayonara, Suckers

Florida’s new snare tactic for HIV positive sex workers

POZ Magazine

Waiting to Exhale

In November, some Americans will vote to burn more than a presidential hopeful.

POZ Magazine

Pos & Neg

Utah capped its ADAP enrollment in July, joining 10 other strapped states and hiking the national ADAP wait list to 1,629.

POZ Magazine

Fit to Print

Canadian inmates get legal, virally safer tattoos

POZ Magazine

Website of the Month

Got HIV, a vagina and an Internet connection? Click on over to www.women-alive.org for femme facts and forums.

POZ Magazine

Milestones

In July, the feds demanded that the University of Southern California repay $1.08 million in mismanaged HIV-counselor training funds.

POZ Magazine

Meet Your Host

How HIV affects you depends on a loooong talk between the virus and your body. Let the show begin.

POZ Magazine

Briefs

Sustiva (efavirenz) lowers levels of VFEND (voriconazole, a thrush med), so don’t mix ’em, says Sustiva’s new label.

POZ Magazine

In Stores-and In Store

This year, drug companies have shoehorned daily fistfuls of meds into fewer pills and doses.

POZ Magazine

Brush With Nausea

After I started HIV meds, I developed what my mother would call a sensitive stomach—OJ plus coffee in the morning made me throw up.

POZ Magazine

Rebel With a Cause

Jason Farrell’s works: clean needles and care

POZ Magazine

A Woman’s Guide to Living With HIV Infection

A straightforward manual, probably most useful for newly diagnosed women, with lingo simply explained.

POZ Magazine

Those Other Pills

Vitamins and minerals get their day in the sun

POZ Magazine

Marijuana Mama

Shari Margolese’s son busts her for toking, er, taking her “herbal" meds

POZ Magazine

Found a cure

Mark Tuggle didn’t have a prayer. Then he got a program.

POZ Magazine

Founder’s Letter

There’s a billboard on the West Side Highway, in New York City, sponsored by shoe designer (and new amfAR board chairman) Kenneth Cole.

POZ Magazine

Mailbox

I recently had a horseback-riding accident and was treated very poorly at the hospital

POZ Magazine

Senior Class

Partying with one of America’s oldest HIVers

POZ Magazine

Earthwatch

In July, the Caribbean Community Secretariat accepted Cuba’s offer to train health workers and give the region discount Cuban-made HIV meds.

POZ Magazine

Inside Story

Entry inhibitors—drugs that stop HIV before it gets into your cells—are coming soon.

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.